FLT3LG and cancer: In the present study, we treated mice with ≤1 mg/kg/day of Flt3 ligand, which has been tested in clinical trials for cancer therapy and is well tolerated with little if any side effects even at doses up to 100 mg/kg/day for 14 days39.